Transarterial Chemoembolization within First 3 Months of Sorafenib Initiation Improves Overall Survival in Hepatocellular Carcinoma: A Retrospective, Multi-Institutional Study with Propensity Matching

The objective of this study was to assess whether SOR  + transarterial chemoembolization provides benefit over SOR alone in this setting.

Source: Journal of Vascular and Interventional Radiology : JVIR - February 22, 2018 Category: Radiology Authors: David E. Kaplan, Rajni Mehta, Kathryn D ’Addeo, Terence P. Gade, Tamar H. Taddei Tags: Clinical Study Source Type: research